Hospital Medicine

Toni Choueiri, MD
Division of Medicine, The Cleveland Clinic

Steven R. Deitcher, MD
Director, Clinical Thrombosis and Vascular Research, Section of Vascular Medicine, Department of Cardiovascular Medicine, The Cleveland Clinic

Address: Steven R. Deitcher, MD, Section of Vascular Medicine, Department of Cardiovascular Medicine, S60, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland,OH 44195; e-mail [email protected]

Dr. Deitcher has received grant or research support from Aventis, Pharmacia, and Bristol-Myers Squibb Pharma and is a consultant for and on the speakers’ bureau of Aventis.

Toni Choueiri, MD
Division of Medicine, The Cleveland Clinic

Steven R. Deitcher, MD
Director, Clinical Thrombosis and Vascular Research, Section of Vascular Medicine, Department of Cardiovascular Medicine, The Cleveland Clinic

Address: Steven R. Deitcher, MD, Section of Vascular Medicine, Department of Cardiovascular Medicine, S60, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland,OH 44195; e-mail [email protected]

Dr. Deitcher has received grant or research support from Aventis, Pharmacia, and Bristol-Myers Squibb Pharma and is a consultant for and on the speakers’ bureau of Aventis.

Toni Choueiri, MD
Division of Medicine, The Cleveland Clinic

Steven R. Deitcher, MD
Director, Clinical Thrombosis and Vascular Research, Section of Vascular Medicine, Department of Cardiovascular Medicine, The Cleveland Clinic

Address: Steven R. Deitcher, MD, Section of Vascular Medicine, Department of Cardiovascular Medicine, S60, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland,OH 44195; e-mail [email protected]

Dr. Deitcher has received grant or research support from Aventis, Pharmacia, and Bristol-Myers Squibb Pharma and is a consultant for and on the speakers’ bureau of Aventis.

Marianne Shaw, MD
Department of Rheumatic and Immunologic Diseases, Cleveland Clinic

Address: Marianne Shaw, MD, Department of Rheumatic and Immunologic Diseases, A50, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195

Marianne Shaw, MD
Department of Rheumatic and Immunologic Diseases, Cleveland Clinic

Address: Marianne Shaw, MD, Department of Rheumatic and Immunologic Diseases, A50, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195

Marianne Shaw, MD
Department of Rheumatic and Immunologic Diseases, Cleveland Clinic

Address: Marianne Shaw, MD, Department of Rheumatic and Immunologic Diseases, A50, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195

Steven P. LaRosa, MD
Associate Staff Physician, Department of Infectious Diseases, Cleveland Clinic

Address: Steven P. LaRosa, MD, Department of Infectious Disease, S32, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail [email protected]

Dr. LaRosa has indicated that he owns stock in Eli Lilly and Company.

Steven P. LaRosa, MD
Associate Staff Physician, Department of Infectious Diseases, Cleveland Clinic

Address: Steven P. LaRosa, MD, Department of Infectious Disease, S32, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail [email protected]

Dr. LaRosa has indicated that he owns stock in Eli Lilly and Company.

Steven P. LaRosa, MD
Associate Staff Physician, Department of Infectious Diseases, Cleveland Clinic

Address: Steven P. LaRosa, MD, Department of Infectious Disease, S32, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail [email protected]

Dr. LaRosa has indicated that he owns stock in Eli Lilly and Company.

Stephen A. Mette, MD
Director, Division of Pulmonary and Critical Care Medicine, Maine Medical Center, Portland, Maine; Clinical Associate Professor of Medicine, University of Vermont College of Medicine

Address: Stephan A. Mette, MD, Maine Medical Center, 22 Bramhall Street, Portland, ME 04192-3175; [email protected]

This paper discusses therapies that are not approved by the Food and Drug Administration for the use under discussion.

Stephen A. Mette, MD
Director, Division of Pulmonary and Critical Care Medicine, Maine Medical Center, Portland, Maine; Clinical Associate Professor of Medicine, University of Vermont College of Medicine

Address: Stephan A. Mette, MD, Maine Medical Center, 22 Bramhall Street, Portland, ME 04192-3175; [email protected]

This paper discusses therapies that are not approved by the Food and Drug Administration for the use under discussion.

Stephen A. Mette, MD
Director, Division of Pulmonary and Critical Care Medicine, Maine Medical Center, Portland, Maine; Clinical Associate Professor of Medicine, University of Vermont College of Medicine

Address: Stephan A. Mette, MD, Maine Medical Center, 22 Bramhall Street, Portland, ME 04192-3175; [email protected]

This paper discusses therapies that are not approved by the Food and Drug Administration for the use under discussion.

Thomas P. Noeller, MD, FACEP
Department of Emergency Medicine, Cleveland Clinic

Address: Thomas P. Noeller, MD, FACEP, Department of Emergency Medicine, E19,  Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; [email protected]

This paper discusses therapies that are not approved by the US Food and Drug Administration for the use under discussion.

Thomas P. Noeller, MD, FACEP
Department of Emergency Medicine, Cleveland Clinic

Address: Thomas P. Noeller, MD, FACEP, Department of Emergency Medicine, E19,  Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; [email protected]

This paper discusses therapies that are not approved by the US Food and Drug Administration for the use under discussion.

Thomas P. Noeller, MD, FACEP
Department of Emergency Medicine, Cleveland Clinic

Address: Thomas P. Noeller, MD, FACEP, Department of Emergency Medicine, E19,  Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; [email protected]

This paper discusses therapies that are not approved by the US Food and Drug Administration for the use under discussion.

James C. Pile, MD
Section of Hospital Medicine, Department of General Internal Medicine, Cleveland Clinic

David L. Longworth, MD
Chairman, Department of Infectious Diseases, Cleveland Clinic

Address: James C. Pile, MD, Section of Hospital Medicine, Department of General Internal Medicine, E13, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195, [email protected]

James C. Pile, MD
Section of Hospital Medicine, Department of General Internal Medicine, Cleveland Clinic

David L. Longworth, MD
Chairman, Department of Infectious Diseases, Cleveland Clinic

Address: James C. Pile, MD, Section of Hospital Medicine, Department of General Internal Medicine, E13, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195, [email protected]

James C. Pile, MD
Section of Hospital Medicine, Department of General Internal Medicine, Cleveland Clinic

David L. Longworth, MD
Chairman, Department of Infectious Diseases, Cleveland Clinic

Address: James C. Pile, MD, Section of Hospital Medicine, Department of General Internal Medicine, E13, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195, [email protected]

James N. George, MD
Hematology-Oncology Section, Department of Medicine, The University of Oklahoma Health Sciences Center, Oklahoma City

Sara K. Vesely, PhD
Hematology-Oncology Section, Department of Medicine, The University of Oklahoma Health Sciences Center, Oklahoma City

Address: James N. George, MD, The University of Oklahoma Health Sciences Center, Hematology-Oncology Section, P.O. Box 26901, Oklahoma City, OK 73190; Jim-
[email protected]

James N. George, MD
Hematology-Oncology Section, Department of Medicine, The University of Oklahoma Health Sciences Center, Oklahoma City

Sara K. Vesely, PhD
Hematology-Oncology Section, Department of Medicine, The University of Oklahoma Health Sciences Center, Oklahoma City

Address: James N. George, MD, The University of Oklahoma Health Sciences Center, Hematology-Oncology Section, P.O. Box 26901, Oklahoma City, OK 73190; Jim-
[email protected]

James N. George, MD
Hematology-Oncology Section, Department of Medicine, The University of Oklahoma Health Sciences Center, Oklahoma City

Sara K. Vesely, PhD
Hematology-Oncology Section, Department of Medicine, The University of Oklahoma Health Sciences Center, Oklahoma City

Address: James N. George, MD, The University of Oklahoma Health Sciences Center, Hematology-Oncology Section, P.O. Box 26901, Oklahoma City, OK 73190; Jim-
[email protected]

David R. Thomas, MD
Professor of Medicine, Division of Geriatric Medicine, Saint Louis University

Address: David R. Thomas, MD, Division of Geriatric Medicine, Saint Louis University Health Sciences Center, 1402 South Grand Boulevard, M238, Saint Louis, MO 63104

David R. Thomas, MD
Professor of Medicine, Division of Geriatric Medicine, Saint Louis University

Address: David R. Thomas, MD, Division of Geriatric Medicine, Saint Louis University Health Sciences Center, 1402 South Grand Boulevard, M238, Saint Louis, MO 63104

David R. Thomas, MD
Professor of Medicine, Division of Geriatric Medicine, Saint Louis University

Address: David R. Thomas, MD, Division of Geriatric Medicine, Saint Louis University Health Sciences Center, 1402 South Grand Boulevard, M238, Saint Louis, MO 63104